Photopheresis Products Market

Photopheresis Products Market (Product Type - Open System and Closed System; End User - Hospitals and Clinics; Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections, and Autoimmune Diseases) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • Rep Id : TMRGL14771
  • Published On : Nov 2016
  • No. of Pages : 133
  • Category : Healthcare

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Photopheresis Market

4. Market Overview
     4.1. Introduction
            4.1.1. By Product Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Key Market Indicators
            4.3.1. Region/Country Specific
            4.3.2. Product/Application/Therapeutic Area Specific
            4.3.3. Target Market Specific – Global Scenario
     4.4. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunity
     4.4. Global Photopheresis Products Market Forecast, 2016-2026
            4.4.1. Market Size Forecast
            4.4.2. Pipeline Analysis
     4.5. Organ and Stem Cell Transplantations Overview
     4.6. Photopheresis Therapy Snapshot
     4.7. Global Photopheresis Market Analysis and Forecasts, 2016–2024
            4.7.1. Market Revenue Projections (US$ Mn)
     4.8. Photopheresis Market - Global Supply Demand Scenario
     4.9. Porter’s Five Force Analysis
     4.10. Market Outlook

5. Global Photopheresis Market Analysis and Forecasts, By Product 
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market value Forecast By Product, 2016–2024
            5.4.1. Open ECP system
            5.4.2. Closed ECP system
     5.5. By Product Comparison Matrix
     5.6. Market Attractiveness By Product 

6. Global Photopheresis Market Analysis and Forecasts, By End User 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market value Forecast By End User, 2016–2024
            6.4.1. Hospitals
            6.4.2. Specialty Clinics
     6.5. End User Comparison Matrix
     6.6. Market Attractiveness By End User 

7. Global Photopheresis Market Analysis and Forecasts, By Therapeutic Area 
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Key Trends
     7.4. Market value Forecast By Therapeutic Area, 2016–2024
            7.4.1. Cutaneous T-cell Lymphoma
            7.4.2. Graft-versus-Host Disease
            7.4.3. Transplantation rejection
            7.4.4. Autoimmune Disease
     7.5. Therapeutic Area Comparison Matrix
     7.6. Market Attractiveness By Therapeutic Area 

8. Global Photopheresis Market Analysis and Forecasts, By Region
     8.1. Key Findings
     8.2. Policies and Regulations
     8.3. Market value Forecast By Region
            8.3.1. North America 
            8.3.2. Latin America 
            8.3.3. APAC 
            8.3.4. Europe 
            8.3.5. MEA 
     8.4. Market Attractiveness By Country/Region

9. North America Photopheresis Market Analysis and Forecast
     9.1. Introduction
            9.1.1. Key Findings
            9.1.2. Policies and Regulations
            9.1.3. Price Trend Analysis
            9.1.4. Key Trends
     9.2. Market value Forecast By Product, 2016–2024
            9.2.1. Open ECP system
            9.2.2. Closed ECP system
     9.3. Market value Forecast By End User, 2016–2024
            9.3.1. Hospitals
            9.3.2. Specialty Clinics
     9.4. Market value Forecast By Therapeutic Area, 2016–2024
            9.4.1. Cutaneous T-cell Lymphoma
            9.4.2. Graft-versus-Host Disease
            9.4.3. Transplantation rejection
            9.4.4. Autoimmune Disease
     9.5. Market value Forecast By Country, 2016–2024
            9.5.1. US
            9.5.2. Canada
     9.6. Market Attractiveness Analysis 
            9.6.1. By Product 
            9.6.2. By End User 
            9.6.3. By Therapeutic Area 
            9.6.4. By Country

10. Latin America Photopheresis Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
            10.1.2. Policies and Regulations
            10.1.3. Price Trend Analysis
            10.1.4. Key Trends
     10.2. Market value Forecast By Product, 2016–2024
            10.2.1. Open ECP system
            10.2.2. Closed ECP system
     10.3. Market value Forecast By End User, 2016–2024
            10.3.1. Hospitals
            10.3.2. Specialty Clinics
     10.4. Market value Forecast By Therapeutic Area, 2016–2024
            10.4.1. Cutaneous T-cell Lymphoma
            10.4.2. Graft-versus-Host Disease
            10.4.3. Transplantation rejection
            10.4.4. Autoimmune Disease
     10.5. Market value Forecast By Country, 2016–2024
            10.5.1. Brazil
            10.5.2. Mexico
            10.5.3. Rest of Latin America
     10.6. Market Attractiveness Analysis 
            10.6.1. By Product 
            10.6.2. By End User 
            10.6.3. By Therapeutic Area 
            10.6.4. By Country

11. APAC Photopheresis Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
            11.1.2. Policies and Regulations
            11.1.3. Price Trend Analysis
            11.1.4. Key Trends
     11.2. Market value Forecast By Product, 2016–2024
            11.2.1. Open ECP system
            11.2.2. Closed ECP system
     11.3. Market value Forecast By End User, 2016–2024
            11.3.1. Hospitals
            11.3.2. Specialty Clinics
     11.4. Market value Forecast By Therapeutic Area, 2016–2024
            11.4.1. Cutaneous T-cell Lymphoma
            11.4.2. Graft-versus-Host Disease
            11.4.3. Transplantation rejection
            11.4.4. Autoimmune Disease
     11.5. Market value Forecast By Country, 2016–2024
            11.5.1. Japan
            11.5.2. India
            11.5.3. China
            11.5.4. Rest of APAC
     11.6. Market Attractiveness Analysis 
            11.6.1. By Product 
            11.6.2. By End User 
            11.6.3. By Therapeutic Area 
            11.6.4. By Country

12. Europe Photopheresis Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
            12.1.2. Policies and Regulations
            12.1.3. Price Trend Analysis
            12.1.4. Key Trends
     12.2. Market value Forecast By Product, 2016–2024
            12.2.1. Open ECP system
            12.2.2. Closed ECP system
     12.3. Market value Forecast By End User, 2016–2024
            12.3.1. Hospitals
            12.3.2. Specialty Clinics
     12.4. Market value Forecast By Therapeutic Area, 2016–2024
            12.4.1. Cutaneous T-cell Lymphoma
            12.4.2. Graft-versus-Host Disease
            12.4.3. Transplantation rejection
            12.4.4. Autoimmune Disease
     12.5. Market value Forecast By Country, 2016–2024
            12.5.1. UK
            12.5.2. France
            12.5.3. Germany
            12.5.4. Spain
            12.5.5. Italy
            12.5.6. Russia
            12.5.7. Rest of Europe
     12.6. Market Attractiveness Analysis 
            12.6.1. By Product 
            12.6.2. By End User 
            12.6.3. By Therapeutic Area 
            12.6.4. By Country

13. MEA Photopheresis Market Analysis and Forecast
     13.1. Introduction
            13.1.1. Key Findings
            13.1.2. Policies and Regulations
            13.1.3. Price Trend Analysis
            13.1.4. Key Trends
     13.2. Market value Forecast By Product, 2016–2024
            13.2.1. Open ECP system
            13.2.2. Closed ECP system
     13.3. Market value Forecast By End User, 2016–2024
            13.3.1. Hospitals
            13.3.2. Specialty Clinics
     13.4. Market value Forecast By Therapeutic Area, 2016–2024
            13.4.1. Cutaneous T-cell Lymphoma
            13.4.2. Graft-versus-Host Disease
            13.4.3. Transplantation rejection
            13.4.4. Autoimmune Disease
     13.5. Market value Forecast By Country, 2016–2024
            13.5.1. South Africa
            13.5.2. Saudi Arabia
            13.5.3. UAE
            13.5.4. Rest of MEA
     13.6. Market Attractiveness Analysis 
            13.6.1. By Product 
            13.6.2. By End User 
            13.6.3. By Therapeutic Area 
            13.6.4. By Country

14. Competition Landscape
     14.1. Market Player – Competition Matrix (By Tier and Size of companies)
     14.2. Market Share Analysis By Company (2015)
     14.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            14.3.1. Haemonetics Corporation 
                      14.3.1.1. Company Overview
                      14.3.1.2. Financial Overview
                      14.3.1.3. Product Portfolio
                      14.3.1.4. Business Strategies
                      14.3.1.5. Recent Developments 
            14.3.2. Fresenius Kabi AG
                      14.3.2.1. Company Overview
                      14.3.2.2. Financial Overview
                      14.3.2.3. Product Portfolio
                      14.3.2.4. Business Strategies
                      14.3.2.5. Recent Developments 
            14.3.3. Macopharma
                      14.3.3.1. Company Overview
                      14.3.3.2. Financial Overview
                      14.3.3.3. Product Portfolio
                      14.3.3.4. Business Strategies
                      14.3.3.5. Recent Developments 
            14.3.4. Terumo Corporation
                      14.3.4.1. Company Overview
                      14.3.4.2. Financial Overview
                      14.3.4.3. Product Portfolio
                      14.3.4.4. Business Strategies
                      14.3.4.5. Recent Developments 
            14.3.5. Med Tech Solutions GmbH 
                      14.3.5.1. Company Overview
                      14.3.5.2. Financial Overview
                      14.3.5.3. Product Portfolio
                      14.3.5.4. Business Strategies
                      14.3.5.5. Recent Developments 
            14.3.6. Mallinckrodt Pharmaceuticals 
                      14.3.6.1. Company Overview
                      14.3.6.2. Financial Overview
                      14.3.6.3. Product Portfolio
                      14.3.6.4. Business Strategies
                      14.3.6.5. Recent Developments 

List of Tables

Table 01 Global Photopheresis Products Market Size (US$ Mn) Forecast, by Product Type, 2015–2024
Table 02 Global Photopheresis Products Market Size (US$ Mn), by Therapeutic Area, 2015–2024
Table 03 Global Photopheresis Products Market Size (US$ Mn) Forecast, by End User, 2015–2024
Table 04 Global Photopheresis Products Market Size (US$ Mn) Forecast, by Region, 2015–2024
Table 05 North America Photopheresis Products Market Size (US$ Mn) Forecast, by Product Type, 2015–2024
Table 06 North America Photopheresis Products Market Size (US$ Mn) Forecast, by Therapeutic Area, 2015–2024
Table 07 North America Photopheresis Products Market Size(US$ Mn) Forecast, by End User, 2015–2024
Table 08 North America Photopheresis Products Market Size(US$ Mn) Forecast, by Country, 2015–2024
Table 09 Europe Photopheresis Products Market Size (US$ Mn) Forecast, by Product Type, 2015–2024
Table 10 Europe Photopheresis Products Market Size (US$ Mn) Forecast, by Therapeutic Area, 2015–2024
Table 11 Europe Photopheresis Products Market Size(US$ Mn) Forecast, by End User, 2015–2024
Table 12 Europe Photopheresis Products Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 13 Latin America Photopheresis Products Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
Table 14 Latin America Photopheresis Products Market Size (US$ Mn) Forecast, by Therapeutic Area, 2015–2024
Table 15 Latin America Photopheresis Products Market Size(US$ Mn) Forecast, by End User, 2015–2024
Table 16 Latin America Photopheresis Products Market Size(US$ Mn) Forecast, by Country, 2015–2024
Table 17 Asia Pacific Photopheresis Products Market Size (US$ Mn) Forecast, by Product Type, 2015–2024
Table 18 Asia Pacific Photopheresis Products Market Size (US$ Mn) Forecast, By Therapeutic Area, 2015–2024
Table 19 Asia Pacific Photopheresis Products Market Size(US$ Mn) Forecast, by Product Type, 2015–2024
Table 20 Asia Pacific Photopheresis Products Market Size(US$ Mn) Forecast, by Country, 2015–2024
Table 21 Middle East & Africa Photopheresis Products Market Size (US$ Mn) Forecast, by Product Type, 2015–2024
Table 22 Middle East & Africa Photopheresis Products Market Size (US$ Mn) Forecast, by Therapeutic Area, 2014–2024
Table 23 Middle East & Africa Photopheresis Products Market Size(US$ Mn) Forecast, by End User, 2014–2024
Table 24 Middle East & Africa Photopheresis Products Market Size(US$ Mn) Forecast, by Country, 2015–2024

List of Figures

Figure 01: Global Photopheresis Products Market Size (US$ Mn) Forecast, 2015–2024
Figure 02: Figure 02: Clinical Trials Conducted, by Region (%)
Figure 03: No. of Clinical Trials Carried Out by Academics/Industry
Figure 04: No. of Clinical Trials in Different Phases
Figure 05: No. of Clinical Trials on Disease Indication
Figure 06: Global Organ Transplantations, by Region (%), (2014)
Figure 07: Global Organ Transplantations Volume (2010–2014)
Figure 08: Global Lung Transplantations, by Region (%), (2014)
Figure 09: Global Lung Transplantations Volume (2010–2014)
Figure 10: Global Liver Transplantations, by Region (%), (2014)
Figure 11: Global Liver Transplantations Volume (2010–2014)
Figure 12: Global Kidney Transplantations, by Region (%), (2014)
Figure 13: Global Kidney Transplantation Volume (2010–2014)
Figure 14: Global Stem Cell Transplants, by Type (1996–2012)
Figure 15: Global Stem Cell Transplants Volume (1996–2012)
Figure 16: Global Stem Cell Transplants, by Region (%) (2006–2012)
Figure 17: Regional Stem Cell Transplants Volume (2006–2012)
Figure 18: Global Photopheresis Products Market Value Share By Product (2016)
Figure 19: Global Photopheresis Products Market Value Share By Therapeutic Area (2016)
Figure 20: Global Photopheresis Products Market Value Share By Region (2016)
Figure 21: Global Photopheresis Products Market Value Share By End User (2016)
Figure 22: Global Photopheresis Products Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 23: Photopheresis Products Market Attractiveness Analysis, by Product Type, 2015
Figure 24: Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Open System, 2015–2024
Figure 25: Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Closed System, 2015–2024
Figure 26: Global Photopheresis Products Market Value Share Analysis, by Therapeutic Area, 2016 and 2024
Figure 27: Global Photopheresis Products Market Attractiveness Analysis, by Therapeutic Area, 2015
Figure 28: Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y growth (%), by Cutaneous T-cell Lymphoma, 2015–2024
Figure 29: Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y growth (%), by Graft-versus-Host Disease, 2015–2024
Figure 30: Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y growth (%), by Transplant Rejections, 2015–2024
Figure 31: Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y growth (%), by Autoimmune Diseases, 2015–2024
Figure 32: Global Photopheresis Products Market Value Share Analysis, by End User, 2016 and 2024
Figure 33: Global Photopheresis Products Market Attractiveness Analysis, by End User, 2015
Figure 34: Global Photopheresis Products Market Revenue (US$ Mn) and
Figure 35: Global Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y growth (%), by Specialty Clinics, 2015–2024
Figure 36: Global Photopheresis Products Market Value Share Analysis, by Region, 2016 and 2024
Figure 37: Photopheresis Products Market Attractiveness Analysis, by Region
Figure 38: North America Photopheresis Products Forecast Market Size (US$ Mn) and Y-o-Y, 2015–2024
Figure 39: North America Photopheresis Products Market Attractiveness Analysis, by Country,2015
Figure 40: North America Photopheresis Products Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 41: North America Photopheresis Products Market Attractiveness Analysis, by Product Type, 2015
Figure 42: North America Photopheresis Products Market Value Share Analysis, by Therapeutic Area, 2016 and 2026
Figure 43: North America Photopheresis Products Market Attractiveness Analysis, by Therapeutic Area
Figure 44: North America Photopheresis Products Market Value Share Analysis, by End User, 2016 and 2026
Figure 45: North America Photopheresis Products Market Attractiveness Analysis, by End User, 2015
Figure 46: Europe Photopheresis Products Forecast Market Size (US$ Mn) and Y-o-Y 2015–2024
Figure 47: Europe Photopheresis Products Market Attractiveness Analysis, by Country, 2015–2024
Figure 48: Europe Photopheresis Products Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 49: Europe Photopheresis Products Market Attractiveness Analysis, by Product Type, 2015
Figure 50: Europe Photopheresis Products Market Value Share Analysis, by Therapeutic Area, 2016 and 2026
Figure 51: Europe Photopheresis Products Market Attractiveness Analysis, by Therapeutic Area, 2015
Figure 52: Europe Photopheresis Products Market Value Share Analysis, by End User, 2016 and 2026
Figure 53: Photopheresis Products Market Attractiveness Analysis, by End User, 2015
Figure 54: Latin America Photopheresis Products Forecast Market Size (US$ Mn) and Y-o-Y , 2015–2024
Figure 55: Latin America Photopheresis Products Market Attractiveness Analysis, by Region ,2015
Figure 56: Latin America Photopheresis Products Market Value Share Analysis by Product Type, 2016 and 2026
Figure 57: Latin America Photopheresis Products Market Attractiveness Analysis, by Product Type,2015
Figure 58: Latin America Photopheresis Products Market Value Share Analysis By Therapeutic Area, 2016 and 2026
Figure 59: Latin America Photopheresis Products Market Attractiveness Analysis by Therapeutic Area, 2015
Figure 60: Latin America Photopheresis Products Market Value Share Analysis by End User, 2016 and 2026
Figure 61: Latin America Photopheresis Products Market Attractiveness Analysis by End User, 2015
Figure 62: Asia Pacific Photopheresis Products Forecast Market Size (US$ Mn) and Y-o-Y, 2015–2024
Figure 63: Asia Pacific Photopheresis Products Market Attractiveness Analysis, by Region, 2015
Figure 64: Asia Pacific Photopheresis Products Market Value Share Analysis by Product Type, 2016 and 2026
Figure 65: Asia Pacific Photopheresis Products Market Attractiveness Analysis, by Product Type, 2015
Figure 66: Asia Pacific Photopheresis Products Market Value Share Analysis by Therapeutic Area, 2016 and 2026
Figure 67: Asia Pacific Photopheresis Products Market Attractiveness Analysis, By Therapeutic Area, 2015
Figure 68: Asia Pacific Photopheresis Products Market Value Share Analysis by End User, 2016 and 2026
Figure 69: Asia Pacific Photopheresis Products Market Attractiveness Analysis, by End User, 2015
Figure 70: Middle East & Africa Photopheresis Products Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2024
Figure 71: Middle East & Africa Photopheresis Products Market Attractiveness Analysis, by Country, 2015
Figure 72: Middle East & Africa Photopheresis Products Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 73: Middle East & Africa Photopheresis Products Market Attractiveness Analysis, by Product Type, 2015
Figure 74: Middle East & Africa Photopheresis Products Market Value Share Analysis, by Therapeutic Area, 2016 and 2024
Figure 75: Middle East & Africa Photopheresis Products Market Attractiveness Analysis, by Therapeutic Area, 2015
Figure 76: Middle East & Africa Photopheresis Products Market Value Share Analysis, by End User, 2016 and 2024
Figure 77: Middle East & Africa Photopheresis Products Market Attractiveness Analysis, by End User, 2015
Figure 78: Photopheresis Products Market Share Analysis, by Company (2015)